Pura Vida Investments’s Tandem Diabetes Care TNDM Stock Holding History

Pura Vida Investments’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-81,800	Closed	-$1.7M	–	91
2023 Q3	$1.7M	Sell	81,800 -21,700	-21%	-$596K	0.32%	62
2023 Q2	$2.54M	Buy	+103,500	New	+$3.33M	0.34%	59
2022 Q3	–	Sell	-160,000	Closed	-$9.47M	–	253
2022 Q2	$9.47M	Buy	+160,000	New	+$13.1M	0.55%	51
2021 Q4	–	Sell	-100,000	Closed	-$11.9M	–	308
2021 Q3	$11.9M	Buy	+100,000	New	+$11M	0.36%	71
2021 Q2	–	Sell	-70,800	Closed	-$6.25M	–	273
2021 Q1	$6.25M	Buy	+70,800	New	+$6.58M	0.18%	108

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pura Vida Investments's TNDM Position: Q3 2024 in Review

Pura Vida Investments sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 40,500 shares — an estimated $1.72M sold.

Pura Vida Investments first reported a position in TNDM in Q1 2015 and held it in 10 quarters. The position peaked at $3.68M in Q4 2018. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

Pura Vida Investments reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
Pura Vida Investments sold 40,500 Tandem Diabetes Care shares in Q3 2024, an estimated $1.72M.
Pura Vida Investments first reported a position in Tandem Diabetes Care in Q1 2015 and held it in 10 quarters.
Pura Vida Investments's Tandem Diabetes Care position peaked at $3.68M in Q4 2018.
332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on Pura Vida Investments's 13F filing for Q3 2024, filed 14 Nov 2024.